Key facts
- This page summarizes Eric Easom's Form 4 filing for AN2 Therapeutics, Inc. (ANTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2023, 20:01.
Eric Easom - 15 May 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ANTX
- Reported as of
- 15 May 2023
- Net transaction value
- +$53,770
- SEC form
- 4
- Accepted by SEC
- 15 May 2023, 20:01:16 UTC
- Prior SEC filing
- 24 Feb 2023
- Next SEC filing
- 04 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Easom
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Easom filed Form 4 for AN2 Therapeutics, Inc. (ANTX) on 15 May 2023.
Change
- Previous filing in this sequence was filed on 24 Feb 2023.
- Current net transaction value: +$53,770.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANTX
transaction
Common Stock
Purchase
- Transaction value
- $53,770
- Shares
- +10,000
- Change %
- +0.99%
- Price
- $5.38
- Shares after
- 1,015,766
- Date
- 15 May 2023
- Ownership
- See Footnote
- Footnotes
- F1
ANTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,907
- Date
- 15 May 2023
- Ownership
- Direct
ANTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 97,058
- Date
- 15 May 2023
- Ownership
- See Footnote
- Footnotes
- F2
ANTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 97,058
- Date
- 15 May 2023
- Ownership
- See Footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
Footnote F2
Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
Footnote F3
Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.